Boston Scientific Corporation Cleared To Resume Shipments of All Defibrillators

Boston Business Journal -- Boston Scientific Corp. has received regulatory approval to alter its manufacturing practices and resume U.S. shipments of defibrillators that were affected by a product recall earlier this year.

MORE ON THIS TOPIC